LIU DONGFANG (Chief Medical Officer) sold 52.6% of their position (20K shares) of NUVATION BIO INC. on the open market
Open‑market sale worth $140.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/24/2025ACC: 0001937915-25-000006
Officer· Chief Medical Officer
Since Jul 2022
-20K
Net shares
Net seller
$140.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20K acquired · 40K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
+20K
Price / share
$1.87
Trade value
$37.40K
% of position
111.1%
11/20/2025
18K→38K
Class A Common Stock
Direct
Shares
−20K
Price / share
$7.00
Trade value
$140.07K
% of position
52.6%
11/20/2025
38K→18K
Total
Net shares
+0.00
Net value
-$102.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 11/20/2025 | M · Option Exercise | +20K | $1.87 | $37.40K | 111.1% | 18K | 38K |
| Class A Common Stock Direct | 11/20/2025 | S · Sale | −20K | $7.00 | $140.07K | 52.6% | 38K | 18K |
| Total | +0.00 | -$102.67K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Class A Common Stock
20K shares
Shares
−20K
Strike price
1.87
Held after
450K
Exercisable
—
11/20/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock20K shares | 11/20/2025 | M · Option Exercise | −20K | 1.87 | — | 450K |